PubRank

O Walker

Author PubWeight™ 52.21‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Disposition of chloroquine in man after single intravenous and oral doses. Br J Clin Pharmacol 1983 2.59
2 Abolition of cost-sharing is pro-poor: evidence from Uganda. Health Policy Plan 2005 2.57
3 Plasma chloroquine and desethylchloroquine concentrations in children during and after chloroquine treatment for malaria. Br J Clin Pharmacol 1983 1.77
4 Pruritus and antimalarial drugs in Africans. Lancet 1989 1.70
5 Blood pressure, hypertension and correlates in urbanised workers in Ibadan, Nigeria: a revisit. J Hum Hypertens 1999 1.54
6 The disposition of chloroquine and its main metabolite desethylchloroquine in volunteers with and without chloroquine-induced pruritus: evidence for decreased chloroquine metabolism in volunteers with pruritus. Clin Pharmacol Ther 2000 1.48
7 Parenteral sulphadoxine-pyrimethamine (Fansidar): an effective and safe but under-used method of anti-malarial treatment. Trans R Soc Trop Med Hyg 1991 1.48
8 Reduced in-vitro susceptibility to mefloquine in West African isolates of Plasmodium falciparum. Lancet 1987 1.46
9 Malaria in Nigeria: a revisit. Ann Trop Med Parasitol 1990 1.38
10 On the question of dose-dependent chloroquine elimination of a single oral dose. Clin Pharmacol Ther 1983 1.34
11 The disposition of amodiaquine in Zambians and Nigerians with malaria. Br J Clin Pharmacol 1990 1.34
12 Characterization of chloroquine plasma protein binding in man. Br J Clin Pharmacol 1983 1.21
13 The disposition of chloroquine in healthy Nigerians after single intravenous and oral doses. Br J Clin Pharmacol 1987 1.11
14 The in vivo sensitivity of Plasmodium falciparum to chloroquine and to sulphadoxine-pyrimethamine combination in Ibadan, Nigeria. Trans R Soc Trop Med Hyg 1981 1.09
15 Cerebral malaria in non-paediatric subjects resident in southwestern Nigeria. Afr J Med Med Sci 1993 1.08
16 A longitudinal study of seroreactivities to Plasmodium falciparum antigens in Nigerian infants during their first year of life. Acta Trop 1995 1.06
17 Comparison of the pharmacokinetics of chloroquine after single intravenous and intramuscular administration in healthy Africans. Br J Clin Pharmacol 1986 1.03
18 Single dose disposition of chloroquine in kwashiorkor and normal children--evidence for decreased absorption in kwashiorkor. Br J Clin Pharmacol 1987 1.01
19 Chloroquine sensitivity of Plasmodium falciparum in Ibadan, Nigeria: II. Correlation of in vitro with in vivo sensitivity. Trans R Soc Trop Med Hyg 1981 0.99
20 Studies on Plasmodium falciparum parasitemia and development of anemia in Nigerian infants during their first year of life. Am J Trop Med Hyg 1996 0.97
21 Retinal haemorrhage in cerebral malaria. East Afr Med J 1997 0.96
22 Protein energy malnutrition and cerebral malaria in Nigerian children. J Trop Pediatr 1997 0.92
23 Innate resistance to new antimalarial drugs in Plasmodium falciparum from Nigeria. Trans R Soc Trop Med Hyg 1992 0.91
24 Comparative efficacy of intramuscular artemether and intravenous quinine in Nigerian children with cerebral malaria. Acta Trop 1999 0.87
25 The clinical manifestations of cerebral malaria among Nigerian children with the sickle cell trait. Ann Trop Paediatr 1997 0.87
26 Clinical significance of development of Philadelphia-chromosome negative clones in patients with chronic myeloid leukemia treated with imatinib mesylate. Haematologica 2005 0.86
27 Evaluation of the clinical efficacy and safety of halofantrine in falciparum malaria in Ibadan, Nigeria. Trans R Soc Trop Med Hyg 1991 0.86
28 Effect of HIV/AIDS on household welfare in Uganda rural communities: a review. East Afr Med J 2008 0.85
29 Clinical efficacy of mefloquine in children suffering from chloroquine-resistant Plasmodium falciparum malaria in Nigeria. Trans R Soc Trop Med Hyg 1991 0.85
30 Pharmacokinetics of quinine in African patients with acute falciparum malaria. Pharm World Sci 1998 0.84
31 Chloroquine resistance of Plasmodium falciparum is associated with severity of disease in Nigerian children. Trans R Soc Trop Med Hyg 2002 0.83
32 Pharmacokinetics of chloroquine in renal insufficiency. Afr J Med Med Sci 1985 0.83
33 Sensitivity of Plasmodium falciparum to chloroquine and sulfadoxine/pyrimethamine in Nigerian children. Bull World Health Organ 1990 0.82
34 Effect of Plasmodium falciparum malaria on plasma fibrinopeptide-A (FpA) concentration. Cent Afr J Med 1995 0.81
35 The sensitivity of Plasmodium falciparum to chloroquine and amodiaquine in Ibadan, Nigeria. Trans R Soc Trop Med Hyg 1984 0.81
36 The relationship between the response of Plasmodium falciparum malaria to mefloquine in African children and its sensitivity in vitro. Trans R Soc Trop Med Hyg 1992 0.81
37 Influence of route of administration on the pharmaco-kinetics of chloroquine and desethylchloroquine. Bull World Health Organ 1987 0.80
38 Pitfalls in the diagnosis of malaria: a-parasitaemic severe malaria. J Trop Pediatr 1992 0.79
39 Respiratory distress adversely affects the outcome of childhood cerebral malaria. Trans R Soc Trop Med Hyg 1996 0.78
40 Mefloquine-sulphadoxine-pyrimethamine (Fansimef, Roche) in the prophylaxis of Plasmodium falciparum malaria: a double-blind, comparative, placebo-controlled study. Ann Trop Med Parasitol 1992 0.78
41 Changes in lipid and lipoprotein values during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. J Pak Med Assoc 1994 0.78
42 Hyperparasitaemia: not a reliable indicator of severity or poor prognosis in falciparum malaria in children in endemic African countries. Ann Trop Paediatr 1992 0.78
43 Therapeutic monitoring of chloroquine in pregnant women with malaria. West Afr J Med 2003 0.78
44 Amlodipine as monotherapy in hypertensive Africans: clinical efficacy and safety studies. Afr J Med Med Sci 1996 0.77
45 Neuropsychiatric side effects of mefloquine in Africans. Trans R Soc Trop Med Hyg 1993 0.77
46 Height and weight measurements of Ibadan school children. Afr J Med Med Sci 1996 0.77
47 CHOLERA EPIDEMIOLOGY IN ZAMBIA FROM 2000 TO 2010: IMPLICATIONS FOR IMPROVING CHOLERA PREVENTION AND CONTROL STRATEGIES IN THE COUNTRY. East Afr Med J 2013 0.77
48 Evaluation of lacidipine (a calcium blocker) in the treatment of hypertension in black African people: a double-blind comparison with hydrochlorothiazide. Afr J Med Med Sci 1999 0.77
49 Parenteral therapy of moderately severe malaria: comparison of intramuscular artemether and intramuscular sulfadoxine-pyrimethamine. Trans R Soc Trop Med Hyg 1994 0.76
50 Malaria and the problem of drug resistant Plasmodium falciparum. Afr J Med Med Sci 1993 0.75
51 The effects of doxazosin on plasma lipid and lipoprotein levels in hypertensive patients. Pharmacol Res 1995 0.75
52 Open trial of doxazosin in hypertensive Africans: dose finding, efficacy and safety studies. Afr J Med Med Sci 1996 0.75
53 Artemether in moderately severe and cerebral malaria in Nigerian children. Trans R Soc Trop Med Hyg 1994 0.75
54 Effects of moduretic on plasma lipid and lipoprotein levels in hypertensive African patients. Tokai J Exp Clin Med 1993 0.75
55 Severe falciparum malaria: survival with oral therapy. Trop Geogr Med 1992 0.75
56 Biochemical changes during a cross-over treatment of doxazosin, moduretic and amlodipine in hypertensive patients. J Pak Med Assoc 1996 0.75
57 Biochemical changes during moduretic treatment of hypertension in African patients. Kobe J Med Sci 1995 0.75
58 Biochemical changes during amlodipine treatment in hypertensive patients. Eur J Clin Pharmacol 1994 0.75
59 Assessment of a fixed-dosage combination of atenolol and chlorthalidone (Tenoretic) in hypertensive Nigerians. Afr J Med Med Sci 1990 0.75
60 Influence of baseline values. I: Effects on plasma total cholesterol and triglyceride levels during doxazosin treatment for hypertension. Int J Clin Pharmacol Res 1998 0.75
61 Effects of amlodipine on plasma lipid and lipoprotein levels in hypertensive patients. J Intern Med 1992 0.75